Esophageal Squamous Cell Carcinoma Clinical Trials in Hefei
5 recruitingHefei, China
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
Esophageal Squamous Cell Carcinoma
Daiichi Sankyo510 enrolled88 locationsNCT06644781
Recruiting
Phase 3
Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.
Resectable Esophageal Squamous Cell Carcinoma
Zhigang Li426 enrolled5 locationsNCT05043688
Recruiting
Not Applicable
Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital70 enrolled1 locationNCT06602843
Recruiting
Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab
Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital25 enrolled1 locationNCT06408584
Recruiting
Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell CarcinomaChemoradiotherapyImmunonutrition+1 more
Anhui Provincial Hospital70 enrolled1 locationNCT05833594